NDC 71610-943
Buspirone Hydrochloride 5 mg tablet
On the label: Aphena Pharma Solutions - Tennessee, Inc.. It's repackaged: Aphena Pharma Solutions - Tennessee, Inc. rebottles it from Oxford Pharmaceuticals, LLC's NDC 69584-091.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Oxford Pharmaceuticals, LLC | Birmingham, AL, United States | Makes it | Problems found, fixed voluntarilyNov 3, 2023 · 3 inspections |
Repackaging site
- Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN, United States · repackages it
Recalls
- May 5, 2021 · Class II · Oxford Pharmaceuticals, LLC
Presence of Foreign Tablets/Capsules
Lots: Lot #: C21021A, Exp. 03/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buspirone: every company that makes it
- Form
- tablet, oral
- Strength
- 5 mg
- Approval
- ANDA ANDA075388
- On the market since
- Jul 27, 2020
- Package NDCs
71610-943-5371610-943-6071610-943-8071610-943-92- Official label
- DailyMed (National Library of Medicine), updated Sep 8, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?